Financials
- Market Capitalization 5.7 M
- Employee 19
- Founded 1996
- CEO N/A
- Website bgmsglobal.com
- Headquarter Delaware, United States
- FIGI BBG000CT3XM2
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 4884 | XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 2.54 USD | -1.55% | -4.51% | -11.81% | +182.85% | 6.01 M USD | ||
| 4894 | PCSA Processa Pharmaceuticals, Inc. - Common Stock | 2.06 USD | -3.29% | -2.37% | +7.85% | -7.41% | 5.75 M USD | ||
| 4900 | LIMN Liminatus Pharma, Inc. - Class A Common Stock | 4.23 USD | -3.86% | -16.07% | +3745.45% | +43.39% | 5.68 M USD | ||
| 4901 | BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.18 USD | -75.00% | -77.50% | -77.22% | -88.61% | 5.63 M USD |